Asthma Clinical Trial
— TURIOfficial title:
Teaching Use of Respiratory Inhalers (TURI)
| NCT number | NCT01456494 |
| Other study ID # | 16900A |
| Secondary ID | |
| Status | Completed |
| Phase | N/A |
| First received | |
| Last updated | |
| Start date | July 2009 |
| Est. completion date | July 2010 |
| Verified date | May 2018 |
| Source | University of Chicago |
| Contact | n/a |
| Is FDA regulated | No |
| Health authority | |
| Study type | Interventional |
The purpose of this study is to evaluate the feasibility of enrolling and randomizing
patients into one of two educational interventions to teach appropriate respiratory inhaler
technique and to collect preliminary estimates of the comparative effectiveness of two types
of education.
Teach-to-Goal (TTG) education employs instruction followed by patient "teach-back," then
repeated cycles of learning and assessment until a skill, i.e. respiratory inhaler technique,
is mastered. By contrast, Brief Intervention (BI) education only consists of providing the
patient with verbal and written instruction on the skill, i.e., respiratory inhaler
technique.
The investigators hypothesize that hospital-based TTG compared to BI increases a patient's
ability to learn respiratory inhaler technique. The investigators will test this hypothesis
separately for the MDI and Diskus® devices.
| Status | Completed |
| Enrollment | 50 |
| Est. completion date | July 2010 |
| Est. primary completion date | March 2010 |
| Accepts healthy volunteers | No |
| Gender | All |
| Age group | 18 Years and older |
| Eligibility |
Inclusion Criteria: - 18 years and older - Admission to the inpatient medical service and surgical service - Physician-diagnosed asthma or COPD - Physician plans to discharge patients home on a metered dose inhaler (MDI; e.g., albuterol) Exclusion Criteria: - Currently in an intensive care unit - Physician declines to provide consent - Patient unable to provide assent (history of cognitive impairment, unable to understand English), or declines to provide consent - Previous participant in this study |
| Country | Name | City | State |
|---|---|---|---|
| United States | University of Chicago Medical Center | Chicago | Illinois |
| Lead Sponsor | Collaborator |
|---|---|
| University of Chicago |
United States,
| Type | Measure | Description | Time frame | Safety issue |
|---|---|---|---|---|
| Primary | Number of Participants Misusing Metered-Dose Inhaler (MDI) Post Education Between Teach to Goal (TTG) and Brief Intervention (BI) | 1 hour at the V0-V1 initial hospital study visit | ||
| Secondary | Number of Participants Misusing Diskus Post Education Between TTG and BI | 1 hour at the V0-V1 initial hospital study visit | ||
| Secondary | Number of Participants Reporting Acute Health-related Events 30 Days Post Hospital Discharge Between TTG and BI | 30 days (Visits V0-V2, ie from initial hospital visit to the 30 day post discharge phone interview) | ||
| Secondary | Differences in the Prevalence of Reported Acute Health-related Events 90 Days Post Hospital Discharge Between TTG and BI | 90 days (from Visits V0-V3, ie from initial hospital visit to 90 days day post discharge phone interview) | ||
| Secondary | Self-reported Confidence With Inhaler Technique Versus Actual Technique | For all patients, the investigators compared their baseline self-reported confidence using a 5-point Likert scale and whether they used their inhaler correctly. The investigators define having strong confidence as either "Agree" or "Strongly Agree" when responding to "I know how to use my inhaler correctly." The investigators define correct technique as performing 10 out of 12 steps in the inhaler technique checklist. The following statistic for each arm is for the participants who reported being confident in their inhaler technique, the number of that sub-population that demonstrated satisfactory inhaler technique | 1 hour at Visits V0-V1 initial hospital study visit |
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Terminated |
NCT04410523 -
Study of Efficacy and Safety of CSJ117 in Patients With Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04624425 -
Additional Effects of Segmental Breathing In Asthma
|
N/A | |
| Active, not recruiting |
NCT03927820 -
A Pharmacist-Led Intervention to Increase Inhaler Access and Reduce Hospital Readmissions (PILLAR)
|
N/A | |
| Completed |
NCT04617015 -
Defining and Treating Depression-related Asthma
|
Early Phase 1 | |
| Recruiting |
NCT03694158 -
Investigating Dupilumab's Effect in Asthma by Genotype
|
Phase 4 | |
| Terminated |
NCT04946318 -
Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma
|
Phase 2 | |
| Completed |
NCT04450108 -
Vivatmo Pro™ for Fractional Exhaled Nitric Oxide (FeNO) Monitoring in U.S. Asthmatic Patients
|
N/A | |
| Completed |
NCT03086460 -
A Dose Ranging Study With CHF 1531 in Subjects With Asthma (FLASH)
|
Phase 2 | |
| Completed |
NCT01160224 -
Oral GW766944 (Oral CCR3 Antagonist)
|
Phase 2 | |
| Completed |
NCT03186209 -
Efficacy and Safety Study of Benralizumab in Patients With Uncontrolled Asthma on Medium to High Dose Inhaled Corticosteroid Plus LABA (MIRACLE)
|
Phase 3 | |
| Completed |
NCT02502734 -
Effect of Inhaled Fluticasone Furoate on Short-term Growth in Paediatric Subjects With Asthma
|
Phase 3 | |
| Completed |
NCT01715844 -
L-Citrulline Supplementation Pilot Study for Overweight Late Onset Asthmatics
|
Phase 1 | |
| Terminated |
NCT04993443 -
First-In-Human Study to Evaluate the Safety, Tolerability, Immunogenicity, and Pharmacokinetics of LQ036
|
Phase 1 | |
| Completed |
NCT02787863 -
Clinical and Immunological Efficiency of Bacterial Vaccines at Adult Patients With Bronchopulmonary Pathology
|
Phase 4 | |
| Recruiting |
NCT06033833 -
Long-term Safety and Efficacy Evaluation of Subcutaneous Amlitelimab in Adult Participants With Moderate-to-severe Asthma Who Completed Treatment Period of Previous Amlitelimab Asthma Clinical Study
|
Phase 2 | |
| Completed |
NCT03257995 -
Pharmacodynamics, Safety, Tolerability, and Pharmacokinetics of Two Orally Inhaled Indacaterol Salts in Adult Subjects With Asthma.
|
Phase 2 | |
| Completed |
NCT02212483 -
Clinical Effectiveness and Economical Impact of Medical Indoor Environment Counselors Visiting Homes of Asthma Patients
|
N/A | |
| Recruiting |
NCT04872309 -
MUlti-nuclear MR Imaging Investigation of Respiratory Disease-associated CHanges in Lung Physiology
|
||
| Withdrawn |
NCT01468805 -
Childhood Asthma Reduction Study
|
N/A | |
| Recruiting |
NCT05145894 -
Differentiation of Asthma/COPD Exacerbation and Stable State Using Automated Lung Sound Analysis With LungPass Device
|